69 related articles for article (PubMed ID: 23211503)
1. A review of recent evidence on androgen abuse from interviews with users.
Grant B; Minhas S; Jayasena CN
Curr Opin Endocrinol Diabetes Obes; 2023 Dec; 30(6):285-290. PubMed ID: 37646503
[TBL] [Abstract][Full Text] [Related]
2. Essential blood testing in the patient using androgenic anabolic steroids: a clinical practice guideline for primary care.
Gibbons SM; Moulding M; Bailey K; Stuart K; Wiffen S; Lewington AJ; Parker R; Lippiatt C; Guha N; O'Shea J; Owen M; Abbas A; Barth JH
Br J Gen Pract; 2024 Apr; 74(741):187-190. PubMed ID: 38538136
[No Abstract] [Full Text] [Related]
3. Illicit use of androgens and other hormones: recent advances.
Kanayama G; Pope HG
Curr Opin Endocrinol Diabetes Obes; 2012 Jun; 19(3):211-9. PubMed ID: 22450858
[TBL] [Abstract][Full Text] [Related]
4. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions.
Nieschlag E; Vorona E
Eur J Endocrinol; 2015 Aug; 173(2):R47-58. PubMed ID: 25805894
[TBL] [Abstract][Full Text] [Related]
5. Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.
Frati P; Busardò FP; Cipolloni L; Dominicis ED; Fineschi V
Curr Neuropharmacol; 2015 Jan; 13(1):146-59. PubMed ID: 26074749
[TBL] [Abstract][Full Text] [Related]
6. Anabolic-androgenic steroids and cardiovascular risk.
Liu JD; Wu YQ
Chin Med J (Engl); 2019 Sep; 132(18):2229-2236. PubMed ID: 31478927
[TBL] [Abstract][Full Text] [Related]
7. Anabolic Androgenic Steroid Abuse: The Effects on Thrombosis Risk, Coagulation, and Fibrinolysis.
Chang S; Münster AB; Gram J; Sidelmann JJ
Semin Thromb Hemost; 2018 Nov; 44(8):734-746. PubMed ID: 30267392
[TBL] [Abstract][Full Text] [Related]
8. Testosterone, myocardial function, and mortality.
Bianchi VE
Heart Fail Rev; 2018 Sep; 23(5):773-788. PubMed ID: 29978359
[TBL] [Abstract][Full Text] [Related]
9. Public health impact of androgens.
Kanayama G; Kaufman MJ; Pope HG
Curr Opin Endocrinol Diabetes Obes; 2018 Jun; 25(3):218-223. PubMed ID: 29369918
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of cardiovascular disease in young individuals.
Andersson C; Vasan RS
Nat Rev Cardiol; 2018 Apr; 15(4):230-240. PubMed ID: 29022571
[TBL] [Abstract][Full Text] [Related]
11. Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review.
Roşca AE; Vlădăreanu AM; Mititelu A; Popescu BO; Badiu C; Căruntu C; Voiculescu SE; Onisâi M; Gologan Ş; Mirica R; Zăgrean L
J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33406783
[TBL] [Abstract][Full Text] [Related]
12. Acute Myocardial Infarction in a Young Bodybuilder: A Case Report and Review of the Literature.
Melhem AJ; Araújo AC; Figueiredo FNS; Figueiredo DLA
Am J Case Rep; 2020 Aug; 21():e924796. PubMed ID: 32848124
[TBL] [Abstract][Full Text] [Related]
13. Common Substances That May Contribute to Resistant Hypertension, and Recommendations for Limiting Their Clinical Effects.
Jurca SJ; Elliott WJ
Curr Hypertens Rep; 2016 Oct; 18(10):73. PubMed ID: 27671491
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary hemorrhage following anabolic agent abuse: Two cases.
Hvid-Jensen HS; Rasmussen F; Bendstrup E
Respir Med Case Rep; 2016; 18():45-7. PubMed ID: 27330949
[TBL] [Abstract][Full Text] [Related]
15. Soccer and Sudden Cardiac Death in Young Competitive Athletes: A Review.
Higgins JP; Andino A
J Sports Med (Hindawi Publ Corp); 2013; 2013():967183. PubMed ID: 26464886
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular manifestations of anabolic steroids in association with demographic variables in body building athletes.
Gheshlaghi F; Piri-Ardakani MR; Masoumi GR; Behjati M; Paydar P
J Res Med Sci; 2015 Feb; 20(2):165-8. PubMed ID: 25983770
[TBL] [Abstract][Full Text] [Related]
17. Androgen abuse and increased cardiac risk.
Higgins JP; Heshmat A; Higgins CL
South Med J; 2012 Dec; 105(12):670-4. PubMed ID: 23211503
[TBL] [Abstract][Full Text] [Related]
18. Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources.
Santos MA; Oliveira CV; Silva AS
Subst Use Misuse; 2014 Jul; 49(9):1132-7. PubMed ID: 24832723
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
